Just in time for the election cycle, Joe Biden announced that he will ask Congress for more funding for a new COVID-19 vaccine. According to Biden, apparently, the last few did not work out so well: “I signed off this morning on a proposal we have to present to the Congress a request for additional funding for a new vaccine that is necessary, that works.”
MAFA – MAKE AMERICA FEARFUL AGAIN
The Biden team needs COVID-19 to be an emergency again so that they can continue to push through the inane agenda on other measures such as student loan debt amnesty, climate change, and (enter bogus policy here).
Biden is going to create another COVID-19 emergency because previous vaccines are failures and we need a “new vaccine … that works.” In Biden’s view, anything that doesn’t prevent COVID-19 cases, even among people who are not at serious risk from the virus, is going to be something that doesn’t work.
SLOW THE SPREAD – DEJA VU ALL OVER AGAIN
Democrats and their liberal base are already giddy about the prospect, “We get to stay home again? Yippee!!”
These lockdown gadflies and “healthcare bureaucrats” will dutifully follow along with this destructive plan and begin imposing restrictions on everyday life. Some schools are already doing so without the green light from Biden.
Oy-vey.
With Joe Biden, EVERYTHING is a CRISIS (OMG, THE SKY IS FALLING, THE SKY IS FALLING) or an EMERGENCY (RUN FOR YOUR LIVES, HIDE IN YOUR BASEMENTS, THE SKY IS GOING TO FALL), both of which have literally made Joe Biden, THE BIG GUY, THE TEFLON DON, Robin Ware, Robert L. Peters, or JRB Ware, into a literal DICTATOR!
Why we need a new COVID vaccine which means another Biden “emergency” to scare the crap out of people because it is “from the bottom up and the middle out” to reward those at the top, to wit:
Reuters
“Drug companies face COVID cliff in 2023 as sales set to plummet”
By Michael Erman and Patrick Wingrove
February 6, 2023
NEW YORK, Feb 6 (Reuters) – Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their windfalls wisely.
Western drugmakers including Pfizer Inc, BioNTech SE, Moderna Inc, Gilead Sciences Inc, AstraZeneca Plc and Merck & Co are estimated to have brought in about $100 billion in revenue from COVID vaccines and treatments in 2022.
Company and analyst estimates suggest those sales could fall by nearly two-thirds this year due to built up product inventories around the world including in the countries that pay the most.
Population immunity from high rates of vaccination and previous infections means that demand for treatments could dip as well.
Pfizer has been the biggest corporate beneficiary of the pandemic financially, with more than $56 billion in 2022 revenue from the vaccine it developed with German partner BioNTech and from its COVID-19 antiviral treatment Paxlovid.
Pfizer has said it expects that revenue to drop to around $21.5 billion in 2023, although some analysts believe that forecast is overly optimistic.
“We remain skeptical that COVID revenues will grow in 2024 and beyond,” JP Morgan analyst Chris Schott said in a research note, adding that vaccination rates could fall even further than the significant decline seen with booster shots in 2022.
Vaccine maker Moderna also expects 2023 revenue to fall sharply.
The company’s only product – its messenger RNA COVID vaccine – pulled in around $18.4 billion in 2022.
Analysts expect that to drop to around $7 billion in 2023.
Moderna shares are up in recent months, but a $173.25 closing price on Friday is more than 65% off their pandemic high of close to $500 in August 2021.
Merck reported sales of $5.7 billion from the treatment last year.
Analysts expect that to drop below $1 billion this year.
Merck had over $59 billion in total sales in 2022.
Eli Lilly and Co made $2 billion in 2022 from monoclonal antibody COVID treatments and is not expecting any revenue from the business in 2023.
The U.S. Food and Drug Administration pulled its authorization of Lilly’s latest antibody bebtelovimab in November because it was not effective against circulating Omicron subvariants.
“We did fine with COVID,” Eli Lilly CEO Dave Ricks said in an interview.
“We made a little bit of money with it.”
*****************
Reuters
“S&P 500, Nasdaq end lower on first day of August in busy earnings week”
By Echo Wang
August 1, 2023
Among pharmaceutical heavyweights, Pfizer edged lower in choppy trading after the drugmaker’s quarterly revenue fell short of Wall Street expectations, hit by declining sales of its COVID-19 products.
*****************
Reuters
“S&P 500, Dow gain on boost from Cisco”
By Saeed Azhar and Amruta Khandekar
August 17, 2023
Shares of Pfizer rose 2.9% as the company said its updated COVID-19 shot, which is being tested against emerging variants, showed neutralizing activity against the “Eris” subvariant in a study conducted on mice.
Vaccine makers Moderna and Novavax also rose as U.S. data showed COVID-19-related hospitalizations up more than 40% from recent lows hit in June.
Like ALL dictators, Joe Biden, like Joe Stalin befo9re him, rules by instilling fear on people.
DO NOT cross Joe Biden – you will regret it!
Dictatorships are often characterised by some of the following: suspension of civil liberties; proclamation of a state of emergency; rule by decree; repression of political opponents; not abiding by the procedures of the rule of law; and the existence of a cult of personality centered on the leader.
That is an apt description of Joseph Robinette Biden, Junior, aka THE BIG GUY, THE TEFLON DON, Robin Ware, Robert L. Peters, Celtic, or JRB Ware.
Interestingly, NBC News has an article about Celtic rules America titled “How Dictators Keep Control” by continuously instilling fear in people by Eric Niiler on Dec. 21, 2011, where we learn that psychologists and sociologists say dictators like Joe Biden are able to spread fear among their people, and place themselves as their only salvation.
Manufacturing an external threat helps keep the society off balance and collectively paranoid as well, as dictators like Joe Biden also exploit a well-known instinct for most people to seek protection from a strong leader, according to Alice LoCicero, a Cambridge, Mass.-based clinical psychologist and researcher on leadership and terrorism.
“Our behavior is still affected by what went on thousands of years ago,” LoCicero said.
“It’s easier to understand why it’s adaptive and common for people to bond to powerful leaders.”
“In Darwinian evolution, the people who bonded with the leader survived.”
“That instinct got passed along.”
Dictators like Joe Biden are also able to rule with more practical tools, such as fear and control of information, according to Jerrold Post, director of the political psychology program at George Washington University.
“Controlling information and controlling dissent are part of what goes into maintaining a totalitarian state,” Post said.